Tamoxifen-induced ER- a –SRC-3 interaction in HER2 positive human breast cancer; a possible mechanism for ER isoform specific recurrence
By M. M. Ilroy, F. Fleming, Y. Buggy, A. Hill, L. Young, M. Mc. 2006
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
Citations in the corpus
- EgoNet: identification of human disease ego-network modules (2014, background): “For example, overexpression of NCOA3, especially in conjunction with high levels EGF receptor (EGFR) and HER2 (ERBB2), is associated with poor outcome after tamoxifen treatment [53,54].”